Department of Veterans Affairs (VA): NAICS 325413 — In-Vitro Diagnostic Substance Manufacturing

5open solicitations
$129.5Mobligated in FY2026
310contracts ending within 18 months

Open solicitations

Open any solicitation for a free AI read of its package — deal-breakers and risks, each quoted from the page it came from. With a free account, FedSift also builds its compliance matrix.

How VA NAICS 325413 spends

FY2021$136.5M
FY2022$371.4M
FY2023$114.2M
FY2024$115.6M
FY2025$105.6M
FY2026$129.5M
FY2027*$53.1M

Contract obligations by federal fiscal year (October–September), from USASpending.gov award data. IDIQ ceilings are excluded. * The current year is partial, and USASpending lags 4–8 weeks.

VA NAICS 325413 contracts expiring in the next 18 months

310 contracts worth $136.0M.

IncumbentBuyerWhatValueEndsEst. solicitationRecord
FISHER SCIENTIFIC COMPANY L.L.C.Department of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$349K23 November 2026Now / imminentDetails
GOVERNMENT SCIENTIFIC SOURCE INCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$171K23 November 2026Now / imminentDetails
BIOMERIEUX INCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$61K28 November 2026Now / imminentDetails
BIOFIRE DIAGNOSTICS LLCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$644K30 November 2026Now / imminentDetails
BECKMAN COULTER, INCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$641K (6 orders)30 November 2026Now / imminentDetails
ABBOTT MOLECULAR INC.Department of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$350K30 November 2026Now / imminentDetails
CEPHEIDDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$215K30 November 2026Now / imminentDetails
QIAGEN, LLCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$107K30 November 2026Now / imminentDetails
SEBIA, INC.Department of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$103K30 November 2026Now / imminentDetails
SEBIA, INC.Department of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$82K30 November 2026Now / imminentDetails
ROCHE DIAGNOSTICS CORPORATIONDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$73K30 November 2026Now / imminentDetails
HELENA LABORATORIES CORPORATIONDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$37K30 November 2026Now / imminentDetails
WERFEN USA LLCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$28K30 November 2026Now / imminentDetails
BIOMERIEUX INCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$516K (6 orders)02 December 2026Now / imminentDetails
BIOMERIEUX INCDepartment of Veterans Affairs325413 In-Vitro Diagnostic Substance Manufacturing$43K02 December 2026Now / imminentDetails

Contracts and task orders from USASpending.gov (FPDS) whose period of performance ends within 18 months, valued at $25K or more, excluding IDIQ ceilings and government-owned, contractor-operated facility contracts. Co-terminous orders from the same vendor, agency, NAICS and PSC ending in the same month are grouped. The solicitation date is an estimate (about six months before the contract ends): FedSift does not know whether a follow-on has been posted, so check SAM.gov.

NAICS 325413 across every agency → · Everything VA has open →

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app